Literature DB >> 10748877

The integration of HPV-18 DNA in cervical carcinoma.

S A Corden1, L J Sant-Cassia, A J Easton, A G Morris.   

Abstract

AIMS: Little information is available on the patterns of integration into the host chromosomal DNA of cervical carcinomas of human papillomavirus type 18 (HPV-18) DNA, which is associated with up to 20% of these carcinomas. Because integration of the viral genome may be extremely important in the pathogenesis of cervical carcinoma, the aim of this study was to investigate which regions of HPV-18 DNA are integrated into the cellular DNA of cervical carcinomas.
METHODS: Southern analysis using four subgenomic probes covering the entire HPV-18 genome was used to map viral DNA integrated within cellular DNA. The polymerase chain reaction (PCR) was used to confirm the presence of specific regions of the viral genome.
RESULTS: In all 11 carcinomas there was a single major HPV-18 DNA integrant, retaining approximately 4000 bp of HPV-18 DNA, indicating that approximately half of the virus genome had been lost upon integration. Southern analysis suggested strongly that the viral breakpoint was within the E1/E2 gene boundary, with concomitant loss of part or all of the E2 ORF (open reading frame), all of the E4, E5, and L2 ORFs and part of the L1 ORF. These data were supported by the PCR results, which confirmed that the region of integrated HPV-18 DNA from nucleotides 6558 to 162 was present in all the carcinoma samples studied. Assuming that no genomic rearrangements, deletions, or insertions had occurred, 4131 bp of integrated HPV-18 DNA could be accounted for in eight cervical carcinoma samples. The results of Southern analysis also suggested that integration of HPV-18 DNA may have occurred at a specific host chromosomal site.
CONCLUSIONS: Broadly, the viral sequences retained upon HPV-18 integration resemble those found when HPV-16 is integrated. However, it appears that the HPV-18 E2 region is more consistently deleted.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10748877      PMCID: PMC395710          DOI: 10.1136/mp.52.5.275

Source DB:  PubMed          Journal:  Mol Pathol        ISSN: 1366-8714


  42 in total

1.  Transcriptional differences of the human papillomavirus type 16 genome between precancerous lesions and invasive carcinomas.

Authors:  H Shirasawa; Y Tomita; K Kubota; T Kasai; S Sekiya; H Takamizawa; B Simizu
Journal:  J Virol       Date:  1988-03       Impact factor: 5.103

2.  Physical state and biological activity of human papillomavirus genomes in precancerous lesions of the female genital tract.

Authors:  H Lehn; L L Villa; F Marziona; M Hilgarth; H G Hillemans; G Sauer
Journal:  J Gen Virol       Date:  1988-01       Impact factor: 3.891

3.  Integration of papillomavirus DNA near myc genes in genital carcinomas and its consequences for proto-oncogene expression.

Authors:  J Couturier; X Sastre-Garau; S Schneider-Maunoury; A Labib; G Orth
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

4.  The human papillomavirus type 16 E2 transcription factor binds with low cooperativity to two flanking sites and represses the E6 promoter through displacement of Sp1 and TFIID.

Authors:  S H Tan; L E Leong; P A Walker; H U Bernard
Journal:  J Virol       Date:  1994-10       Impact factor: 5.103

5.  The link between integration and expression of human papillomavirus type 16 genomes and cellular changes in the evolution of cervical intraepithelial neoplastic lesions.

Authors:  B Daniel; A Rangarajan; G Mukherjee; E Vallikad; S Krishna
Journal:  J Gen Virol       Date:  1997-05       Impact factor: 3.891

6.  Dose-dependent regulation of the early promoter of human papillomavirus type 18 by the viral E2 protein.

Authors:  G Steger; S Corbach
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

7.  Changes in the physical state and expression of human papillomavirus type 16 in the progression of cervical intraepithelial neoplasia lesions analysed by PCR.

Authors:  B Daniel; G Mukherjee; L Seshadri; E Vallikad; S Krishna
Journal:  J Gen Virol       Date:  1995-10       Impact factor: 3.891

8.  Chromosome localization in normal human cells and neuroblastomas of a gene related to c-myc.

Authors:  M Schwab; H E Varmus; J M Bishop; K H Grzeschik; S L Naylor; A Y Sakaguchi; G Brodeur; J Trent
Journal:  Nature       Date:  1984 Mar 15-21       Impact factor: 49.962

9.  Genome amplification of human papillomavirus types 16 and 18 in cervical carcinomas is related to the retention of E1/E2 genes.

Authors:  J Berumen; L Casas; E Segura; J L Amezcua; A Garcia-Carranca
Journal:  Int J Cancer       Date:  1994-03-01       Impact factor: 7.396

10.  Molecular analysis of cellular loci disrupted by papillomavirus 16 integration in cervical cancer: frequent viral integration in topologically destabilized and transcriptionally active chromosomal regions.

Authors:  K B Choo; C M Chen; C P Han; W T Cheng; L C Au
Journal:  J Med Virol       Date:  1996-05       Impact factor: 2.327

View more
  35 in total

1.  E2 proteins from high- and low-risk human papillomavirus types differ in their ability to bind p53 and induce apoptotic cell death.

Authors:  Joanna L Parish; Anna Kowalczyk; Hsin-Tien Chen; Geraldine E Roeder; Richard Sessions; Malcolm Buckle; Kevin Gaston
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

2.  Regulation of human papillomavirus type 16 E7 activity through direct protein interaction with the E2 transcriptional activator.

Authors:  Noor Gammoh; Helena Sterlinko Grm; Paola Massimi; Lawrence Banks
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

3.  Type-specific interaction between human papillomavirus type 58 E2 protein and E7 protein inhibits E7-mediated oncogenicity.

Authors:  Xin Wang; Mei Qi; Xiuping Yu; Yan Yuan; Weiming Zhao
Journal:  J Gen Virol       Date:  2012-03-21       Impact factor: 3.891

4.  Cancer of the cervix - from bleak past to bright future; a review, with an emphasis on cancer of the cervix in malaysia.

Authors:  Othman Nor Hayati
Journal:  Malays J Med Sci       Date:  2003-01

Review 5.  Mobile elements and viral integrations prompt considerations for bacterial DNA integration as a novel carcinogen.

Authors:  Kelly M Robinson; Julie C Dunning Hotopp
Journal:  Cancer Lett       Date:  2014-06-21       Impact factor: 8.679

6.  Quantitative measurement of human papillomavirus type 16 e5 oncoprotein levels in epithelial cell lines by mass spectrometry.

Authors:  Ziad Sahab; Sawali R Sudarshan; Xuefeng Liu; YiYu Zhang; Alexander Kirilyuk; Christopher M Kamonjoh; Vera Simic; Yuhai Dai; Stephen W Byers; John Doorbar; Frank A Suprynowicz; Richard Schlegel
Journal:  J Virol       Date:  2012-06-27       Impact factor: 5.103

7.  Stability of the human papillomavirus type 18 E2 protein is regulated by a proteasome degradation pathway through its amino-terminal transactivation domain.

Authors:  S Bellanger; C Demeret; S Goyat; F Thierry
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

8.  Type-specific detection of human papillomaviruses in Kazakh esophageal squamous cell carcinoma by genotyping both E6 and L1 genes with MALDI-TOF mass spectrometry.

Authors:  Hong-Chao Dong; Xiao-Bin Cui; Liang-Hai Wang; Man Li; Yao-Yuan Shen; Jian-Bo Zhu; Cheng-Fang Li; Jian-Ming Hu; Shu-Gang Li; Lei Yang; Wen-Jie Zhang; Yun-Zhao Chen; Feng Li
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

Review 9.  Papillomavirus interaction with cellular chromatin.

Authors:  Jianxin You
Journal:  Biochim Biophys Acta       Date:  2009-09-26

10.  Abrogation of the Brd4-positive transcription elongation factor B complex by papillomavirus E2 protein contributes to viral oncogene repression.

Authors:  Junpeng Yan; Qing Li; Sam Lievens; Jan Tavernier; Jianxin You
Journal:  J Virol       Date:  2010-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.